Rational design of a meningococcal antigen inducing broad protective immunity

Maria Scarselli1, Beatrice Aricò, Brunella Brunelli

  • 1Novartis Vaccines and Diagnostics S.r.l., Via Fiorentina 1, 53100 Siena, Italy.

Summary

Scientists engineered a novel chimeric antigen targeting the factor H binding protein (fHBP) of Neisseria meningitidis. This single antigen elicits broad immunity against all known fHBP variants, advancing vaccine development for meningitis.